|

SOX regimen Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: Oxaliplatin + S-1 (tegafur/gimeracil/oteracil)

Pipeline

Phase 2: 1

Top Sponsors

  • Jinbo Yue1

Indications

  • Gastric Adenocarcinoma1
  • Stomach Neoplasms1
  • Cancer1

Other1 trial

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.